Groundbreaking new test 90% accurate in finding patients at high risk of bowel cancer

Scientists believe a groundbreaking new test may predict patients at high risk of developing bowel cancer with 90 per cent accuracy.

Research, published in the journal Gut on Thursday, could lead to blood testing for the thousands of Britons with irritable bowel diseases (IBD) ulcerative colitis or Crohn’s who were most at risk of developing bowel cancer, and help avoid some invasive procedures.